Astria Therapeutics, Inc. (ATXS)

NASDAQ: ATXS · Real-Time Price · USD

4.370

+0.140 (3.31%)

At close: May 12, 2025, 4:00 PM

4.450

+0.080 (1.83%)

After-hours: May 12, 2025, 4:59 PM EDT

Astria Therapeutics Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	2015 - 2019
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	2015 - 2019
Selling, General & Admin	35.25	26.03	19.73	15.15	12.36	Upgrade
Research & Development	76.31	41.8	33.78	15.21	25.08	Upgrade
Operating Expenses	111.56	67.83	53.5	30.36	37.44	Upgrade
Operating Income	-111.56	-67.83	-53.5	-30.36	-37.44	Upgrade
Interest & Investment Income	17.36	10.2	1.72	0.12	0.24	Upgrade
Other Non Operating Income (Expenses)	-0.06	-0.06	-0.06	-0.06	-0.1	Upgrade
EBT Excluding Unusual Items	-94.26	-57.69	-51.83	-30.3	-37.3	Upgrade
Pretax Income	-94.26	-72.89	-51.83	-194.91	-37.3	Upgrade
Net Income	-94.26	-72.89	-51.83	-194.91	-37.3	Upgrade
Preferred Dividends & Other Adjustments	-	-	-	24.44	-	Upgrade
Net Income to Common	-94.26	-72.89	-51.83	-219.35	-37.3	Upgrade
Shares Outstanding (Basic)	56	30	15	9	3	Upgrade
Shares Outstanding (Diluted)	56	30	15	9	3	Upgrade
Shares Change (YoY)	86.44%	106.03%	63.81%	191.81%	63.87%	Upgrade
EPS (Basic)	-1.68	-2.42	-3.55	-24.58	-12.20	Upgrade
EPS (Diluted)	-1.68	-2.42	-3.55	-24.58	-12.20	Upgrade
Free Cash Flow	-81.54	-68.47	-43.62	-30.17	-32.52	Upgrade
Free Cash Flow Per Share	-1.45	-2.27	-2.98	-3.38	-10.63	Upgrade
EBITDA	-	-	-	-	-37.41	Upgrade
D&A For EBITDA	-	-	-	-	0.03	Upgrade
EBIT	-111.56	-67.83	-53.5	-30.36	-37.44	Upgrade

Updated Mar 11, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q